Knudsen J D, Frimodt-Møller N, Espersen F
Department of Clinical Microbiology, Statens Seruminstitut, Copenhagen S, Denmark.
Antimicrob Agents Chemother. 1995 Jun;39(6):1253-8. doi: 10.1128/AAC.39.6.1253.
The purpose of the study was to investigate the correlation of in vitro activity with the in vivo effect and the pharmacokinetics of penicillin in the treatment of infections with pneumococci with various susceptibilities to penicillin. We used 10 pneumococcal strains for which penicillin MICs ranged from 0.016 to 8 micrograms/ml. Time-kill curve experiments were performed with all strains. We found that the effect of penicillin in vitro is concentration independent, with a maximum effect at two to four times the MIC for penicillin-susceptible as well as penicillin-resistant pneumococci. The mouse peritonitis model with an inoculum of approximately 10(6) CFU, to which mucin was added, resulted in a reproducible lethal infection with the pneumococci. The 50% effective dose was determined for each strain, and we found a highly significant correlation between the log MIC and the log 50% effective dose of penicillin against these strains (P < 0.01). Furthermore, it was shown that the most important pharmacokinetic parameter determining the effect of penicillin in vivo was the time that the concentration of penicillin in serum was greater than the MIC.
本研究的目的是调查体外活性与体内效应以及青霉素治疗对青霉素敏感性各异的肺炎球菌感染时的药代动力学之间的相关性。我们使用了10株肺炎球菌菌株,其青霉素MIC范围为0.016至8微克/毫升。对所有菌株进行了时间杀菌曲线实验。我们发现,青霉素的体外效应与浓度无关,对于青霉素敏感以及耐药的肺炎球菌,在青霉素MIC的两到四倍时达到最大效应。在接种约10(6)CFU并添加粘蛋白的小鼠腹膜炎模型中,肺炎球菌导致了可重复的致死性感染。确定了每种菌株的50%有效剂量,我们发现青霉素针对这些菌株的log MIC与log 50%有效剂量之间存在高度显著的相关性(P < 0.01)。此外,研究表明,决定青霉素体内效应的最重要药代动力学参数是血清中青霉素浓度高于MIC的时间。